Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Sep;120(9):1706-1718.
doi: 10.1016/j.jfma.2020.12.003. Epub 2020 Dec 15.

Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis

Amar Hassan Khamis et al. J Formos Med Assoc. 2021 Sep.

Abstract

Background/purpose: The aim of this study was to systematically review all COVID-19 publications to summarize the clinical features, assess comorbidities, prevalence, and disease outcomes.

Methods: Included were all COVID-19 published studies between January 1 to July 20, 2020. The random effect model was used to calculate the pooled prevalence and corresponding 95% confidence interval (CI). Publication bias was assessed using the funnel plot for the standard error by logit event.

Results: The mean age of the patients was 46.8 years (95% CI, 41.0-52.6) and males comprised 54.0% (95% CI, 51.3-56.7). Total co-morbidities prevalence was 29.5% (95% CI, 19.0-36.6), with diabetes mellitus being the most prevalent 13.8% (95% CI, 8.7-21.1), followed by hypertension 11.7% (95% CI, 5.7-22.6), and cardiovascular disease 9.7% (95% CI, 6.5-14.2). The most common clinical manifestations were fever, 82.0% (95% CI, 67.7-90.8), cough 54.3% (95% CI, 45.5-62.9), fatigue 30.2% (95% CI, 23.3-38.1), sputum 28.5% (95% CI, 21.2-37.2), sore throat 21.7% (95% CI, 14.6-31.0), and headache 11.0% (95% CI, 7.9-15.2). The most common COVID-19 serious complications were RNA Anemia 98.2% (95% CI, 96.2-99.2), hospitalization 83.7% (95% CI, 76.0-89.3), bilateral pneumonia 70.9% (95% CI, 58.2-81.0); of those hospitalized 43.5% (95% CI, 24.9-64.2) were discharged. Fatality accounted for 10.5% (95% CI 6.8-16.1).

Conclusion: Patients infected with COVID-19 coronavirus showed a wide range of clinical presentation with non-specific symptoms.

Keywords: COVID-19; Clinical features; Epidemic; Meta-analysis; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors have no conflicts of interest relevant to this article.

Figures

Figure 1
Figure 1
PRISMA chart of the selected studies.

References

    1. Mäkelä M., Puhakka T., Ruuskanen O., Leinonen M., Saikku P., Kimpimäki M. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36(2):539–542. - PMC - PubMed
    1. Jan M., Banach B., Susan C. Morphogenesis of coronavirus HCoV-NL63 in cell culture: a transmission electron microscopic study. Open Infect Dis J. 2008;2:52–58. - PMC - PubMed
    1. Adhikari S., Meng S., Wu Y., Yu-Ping M., Rui-Xue Y., Qing-Zhi W. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9:29. doi: 10.1186/s40249-020-00646-x. - DOI - PMC - PubMed
    1. World Health Organization Novel coronavirus (2019-nCoV) - situation report - 10 30. January 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
    1. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi: 10.1016/S0140-6736(20)30154-9. - DOI - PMC - PubMed